Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spark

Showing results (281-290 of 331) with videos related to

Pageof 34
Sort By:
European Journal of Heart Failure|August 19, 2007
Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trialLars G Olsson, Karl Swedberg, John G F Cleland, et al.
European Journal of Heart Failure|June 22, 2007
Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMETMarco Metra, Christian Torp-Pedersen, John G F Cleland, et al.
Peptides|January 24, 2009
GHTD-amide: a naturally occurring beta cell-derived peptide with hypoglycemic activityS G Paule, B Nikolovski, R E Gray, et al.
Injury Epidemiology|November 4, 2025
Rural-urban differences in post-9/11 women veterans' firearm ownership and characteristicsAshley M Griffith, Christin Miller, Nicole M Caulfield, et al.
Science Signaling|August 19, 2025
Hox-C12 coordinates β<sub>2</sub>-adrenoceptor coupling to a cAMP/calcium feedforward loop to drive invasion in triple-negative breast cancerTerrance Lam, Bailey Cardwell, Bonan Liu, et al.
Heart (British Cardiac Society)|January 24, 2007
Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)Christian Torp-Pedersen, Marco Metra, Andrew Charlesworth, et al.
European Journal of Heart Failure|August 25, 2007
Effect of carvedilol and metoprolol on the mode of death in patients with heart failureWillem J Remme, John G Cleland, Leif Erhardt, et al.
BMC Infectious Diseases|November 21, 2014
Improving chlamydia knowledge should lead to increased chlamydia testing among Australian general practitioners: a cross-sectional study of chlamydia testing uptake in general practiceAnna Yeung, Meredith Temple-Smith, Simone Spark, et al.
Journal of Cardiac Failure|July 3, 2007
The safety of amiodarone in patients with heart failureChristian Torp-Pedersen, Marco Metra, Philip Spark, et al.
BMJ Neurology Open|November 3, 2023
STAREE-Mind Imaging Study: a randomised placebo-controlled trial of atorvastatin for prevention of cerebrovascular decline and neurodegeneration in older individualsIan H Harding, Joanne Ryan, Stephane Heritier, et al.
Pageof 34

Showing results (281-290 of 331) with videos related to

Sort By:
Pageof 34
European Journal of Heart Failure|August 19, 2007
Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trialLars G Olsson, Karl Swedberg, John G F Cleland, et al.
European Journal of Heart Failure|June 22, 2007
Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMETMarco Metra, Christian Torp-Pedersen, John G F Cleland, et al.
Peptides|January 24, 2009
GHTD-amide: a naturally occurring beta cell-derived peptide with hypoglycemic activityS G Paule, B Nikolovski, R E Gray, et al.
Injury Epidemiology|November 4, 2025
Rural-urban differences in post-9/11 women veterans' firearm ownership and characteristicsAshley M Griffith, Christin Miller, Nicole M Caulfield, et al.
Science Signaling|August 19, 2025
Hox-C12 coordinates β<sub>2</sub>-adrenoceptor coupling to a cAMP/calcium feedforward loop to drive invasion in triple-negative breast cancerTerrance Lam, Bailey Cardwell, Bonan Liu, et al.
Heart (British Cardiac Society)|January 24, 2007
Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)Christian Torp-Pedersen, Marco Metra, Andrew Charlesworth, et al.
European Journal of Heart Failure|August 25, 2007
Effect of carvedilol and metoprolol on the mode of death in patients with heart failureWillem J Remme, John G Cleland, Leif Erhardt, et al.
BMC Infectious Diseases|November 21, 2014
Improving chlamydia knowledge should lead to increased chlamydia testing among Australian general practitioners: a cross-sectional study of chlamydia testing uptake in general practiceAnna Yeung, Meredith Temple-Smith, Simone Spark, et al.
Journal of Cardiac Failure|July 3, 2007
The safety of amiodarone in patients with heart failureChristian Torp-Pedersen, Marco Metra, Philip Spark, et al.
BMJ Neurology Open|November 3, 2023
STAREE-Mind Imaging Study: a randomised placebo-controlled trial of atorvastatin for prevention of cerebrovascular decline and neurodegeneration in older individualsIan H Harding, Joanne Ryan, Stephane Heritier, et al.
Pageof 34